Atlas Trials

A Study With Teduglutide (Revestive®) in Adults With Short Bowl Syndrome

Clinical trial NCT04883606 · COMPLETED

Trial details

NCT number
NCT04883606
Sponsor
Takeda
Status
COMPLETED
Study type
OBSERVATIONAL
Short Bowel Syndrome
Start date
2022-01-26
Primary completion
2023-07-24
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.